- Category
- Micro (2021-22)
- Udyam number
- UDYAM-WB-06-0005816

Medipas Pharma Private Limited
About Medipas Pharma Private Limited
Data last updated:
Medipas Pharma Private Limited is a private limited company based in Siliguri, West Bengal, India. It operates in the wholesale trading and distribution segment of the home appliances and consumer durables sector. It was incorporated on 10 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U51397WB2021PTC247841. Its GSTIN is 19AAOCM9498H1ZF (West Bengal).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shyamal Kumar Mandal and Parbati Mandal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Dalim Kumar Sinha Sarada Pally Shibmandir Kadamtala, Siliguri, West Bengal, India – 734011.
As per the financials filed for FY 2025, the company reported a revenue of ₹32.5 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹52,733 (net margin 1.6%) and EBITDA of ₹57,593 (EBITDA margin 1.8%).
Medipas Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-06-0005816).
Company details
Recognitions & Rankings of Medipas Pharma
Contact details
Medipas Pharma Private Limited's registered office is in Siliguri, West Bengal. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Dalim Kumar Sinha Sarada Pally Shibmandir Kadamtala, Siliguri, West Bengal, India – 734011
- IndustryHome Appliances, Wholesale, Household Goods
To see the full contact details of Medipas Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medipas Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Medipas Pharma Private Limited, buy the company report.
Financials of Medipas Pharma Private Limited
FY 2025 filings availableMedipas Pharma Private Limited reported revenue of ₹32.5 Lakh (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 8% in the latest year. EBITDA rose 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹57,593 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹52,733 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.8% | |||
| Net Profit Margin | 1.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Medipas Pharma Private Limited, buy the company report.
Board of directors of Medipas Pharma Private Limited
Medipas Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shyamal Kumar Mandal | Director | 10 Sep 2021 | 5 Years 1 Months | Current |
| Parbati Mandal | Director | 10 Sep 2021 | 5 Years 1 Months | Current |
Peer comparison
Medipas Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sweetyet Development Distribution (India) Private Limited | ₹32.54 Lakh (FY 2025) | 8.0% | Mumbai, Maharashtra, India | |||
| Naglaman Farmer Producer Company Limited | ₹32.53 Lakh (FY 2025) | 51952.0% | Chandauli, Uttar Pradesh, India | |||
| Shree Devkrupa Farmer Producer Company Limited | ₹32.52 Lakh (FY 2025) | 28.0% | Hingoli, Maharashtra, India | |||
| Velo Life Sciences Private Limited | ₹32.52 Lakh (FY 2025) | 40.0% | Bangalore, Karnataka, India | |||
| Utkrisht Lifestyle Private Limited | ₹32.51 Lakh (FY 2025) | Delhi, India | ||||
| Medipas Pharma Private Limitedthis company | ₹32.5 Lakh (FY 2025) | ₹52,733 | 1.6% | 8.0% | Siliguri, West Bengal, India | |
| Dinu Gems Private Limited | ₹32.5 Lakh (FY 2024) | -17.0% | Mumbai, Maharashtra, India | |||
| Focus Exim Private Limited | ₹32.5 Lakh (FY 2025) | -63.0% | New Delhi, Delhi, India | |||
| Gudberg Nutraceuticals Private Limited | ₹32.49 Lakh (FY 2025) | -9.0% | Pune, Maharashtra, India | |||
| Riya Agro Industries Private Limited | ₹32.47 Lakh (FY 2025) | Ahmedabad, Gujarat, India | ||||
| Yana Distributors Private Limited | ₹32.45 Lakh (FY 2025) | 73.0% | Bhopal, Madhya Pradesh, India |
To see the full peer comparison of Medipas Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medipas Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medipas Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medipas Pharma Private Limited has 1 active EPFO establishment as of Apr 01, 2024.
GST
Medipas Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAOCM9498H1ZF | West Bengal | Active | 26 Mar 2022 |
To see the full GST registrations and return filing status of Medipas Pharma Private Limited, buy the company report.
Recent activity
Medipas Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Parbati Mandal was appointed as Director on 10 Sep 2021.
Frequently asked questions
Medipas Pharma is an active private limited company based in Siliguri, West Bengal, India. The company works in wholesale, within the home appliances industry. It was incorporated on 10 September 2021 (5+ years old) and is registered under CIN U51397WB2021PTC247841.
Medipas Pharma has 2 current directors:
- Shyamal Kumar Mandal - Director
- Parbati Mandal - Director
The latest financial statements of Medipas Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Medipas Pharma is 19AAOCM9498H1ZF, registered in West Bengal.
The CIN (Corporate Identification Number) of Medipas Pharma is U51397WB2021PTC247841. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medipas Pharma was incorporated on 10 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Medipas Pharma by revenue are Sweetyet Development Distribution (India) Private Limited, Naglaman Farmer Producer Company Limited, Shree Devkrupa Farmer Producer Company Limited, Velo Life Sciences Private Limited, Utkrisht Lifestyle Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Parbati Mandal was appointed as Director on 10 Sep 2021. Shyamal Kumar Mandal was appointed as Director on 10 Sep 2021.
Yes, Medipas Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-06-0005816).
The registered office of Medipas Pharma is at CO Dalim Kumar Sinha Sarada Pally Shibmandir Kadamtala, Siliguri, West Bengal, India – 734011.
Medipas Pharma operates in the home appliances industry, in the wholesale segment.

